Ociperlimab

An investigational humanized monoclonal antibody designed to bind to TIGIT with high specificity and affinity
All Types
All Types
Reading
4
Slide-Kit
6
Video
5
Latest
Latest
latest
Oldest
oldest
All Types
All Types
Reading
4
Slide-Kit
6
Video
5
Latest
Latest
latest
Oldest
oldest
Suggested:
CLL
EHA
ESMO
Hematologic Malignancies
Solid Tumors
WM

Ociperlimab MoA

Ociperlimab (BGB-A1217) is an investigational humanized monoclonal antibody designed to bind and inhibit TIGIT. Watch the MoA video to learn more.

Video
20 Mar 2024
Eric Van Cutsem, Josep Tabernero, Michel Decreux, Lizzy Smyth, Lesley Fallowfield

BeiGene 2023 Masterclass in GI Cancers

This masterclass on gastrointestinal (GI) cancers provided clinicians with an overview of the current treatment landscape and new therapies for certain GI cancers.

Video
10 Nov 2023